A new study shows that aging isn't a totally gradual or linear process. While the research comes with caveats, the findings could help us age more gracefully. A pathology professor who believes ...

TOKYO, Oct 3 (Reuters) - Japan's jobless rate in August rose to 2.6% from 2.3% in July, government data showed on Friday. Economists' median forecast was for 2.4%. Sign up here. The jobs-to-applicants ...

Ultraviolet radiation is more dangerous than it looks. This documentary reveals how UV damages DNA, accelerates aging, and raises the risk of cancer. GM is moving production from Oshawa to Indiana.

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve. But ...

Emma Guttman, MD, PhD, discusses the promising potential of rocatinlimab in targeting the OX40-OX40 ligand pathway for atopic dermatitis treatment. Trial investigator Emma Guttman, MD, PhD, chair of ...

New Jersey was the first state in the nation to provide public funds to candidates for governor after the Gubernatorial Public Financing Program was enacted in 1974. The state has provided public ...

The teenage girl was found dead in the trunk of the 20-year-old singer's Tesla in Los Angeles on Sept. 8 More questions are emerging as authorities continue to investigate the death of Celeste Rivas ...

New research based on adults who were cured of HIV after stem cell transplants may offer hope to ultimately have a global impact on HIV care. A total of 10 individuals with HIV have been cured to date ...

Immune cells can target cancer in the clinic. The ability to test a gene-editing technology in mice on a large scale should improve such immunotherapies. Michael Hudecek is in the Department of ...

Sept 22 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab (BMS) plans to launch schizophrenia drug Cobenfy in the UK next year at a price matching its U.S. list price, it said on Monday. Cobenfy ...